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The effectiveness of repetitive transcranial Direct Current Stimulation (tDCS) on reducing
smoking behaviour has been studied with mixed results. Smoking behaviour is influenced
by affect and context, therefore we choose to use mobile ecological momentary assess-
ments (EMA) to measure changes in smoking behaviour after tDCS.
Methods
In a randomized, placebo-controlled, between subject study, we applied tDCS bilaterally
with the anodal electrode targeting the right DLPFC (https://clinicaltrials.gov/ct2/show/
NCT03027687). Smokers were allocated to six sessions of either active tDCS (n = 35) or
sham tDCS (n = 36) and received two sessions on three different days in one week. They
were asked to keep track of their daily cigarette consumption, craving and affect in an appli-
cation on their mobile phones for three months starting one week before the first tDCS
session.
Results
Number of smoked cigarettes a day progressively decreased up to one week after the last
tDCS session in both conditions. Active treatment had no additional effect on cigarette con-
sumption, craving and affect.
Conclusions
In this exploratory study, repetitive bilateral tDCS over the DLPFC had no effect on daily
smoking behaviour. Future research needs to investigate how motivation to quit smoking
and the number of tDCS sessions affect the efficacy of repetitive tDCS.
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Introduction
Smoking is associated with serious health risks and causes approximately 8 million deaths
worldwide each year [1]. Although the health risks of smoking are generally well known, 1.1
billion people of the global population are still smokers [1]. The maintenance of tobacco addic-
tion may be explained by an interplay of increased reward processing for smoking cues and
decreased self-control over addictive behaviours [2, 3]. One brain area that plays a crucial role
in this interaction is the dorsolateral prefrontal cortex (DLPFC) by its involvement in top
down-control over reward processing [4]. Non-invasive neurostimulation (NIBS) is designed
to directly modulate brain activity in specific brain areas. It is therefore suggested that NIBS
over the DLPFC could enhance cognitive control of executive functioning, hereby reducing
craving and substance use [5].
Transcranical Direct Current Stimulation (tDCS) is a well-tolerable NIBS that has no
known serious adverse effects [6]. tDCS modulates membrane potentials in the brain by
means of small electrical currents [7]. The electrical current flow from the anodal electrode to
the cathodal electrode produces an electrical field that modulates the excitability of underlying
brain areas [8]. This modulation of excitation levels is able to induce changes in behaviour,
mood and cognition [9]. Also, cognitive control processes related to substance use disorder
can be affected by tDCS [10]. Importantly, several studies on addictive behaviours have shown
that tDCS could reduce craving. This effect has been found for a variety of substances, such as
tobacco [11, 12], marijuana [13], cocaine [14], heroin [15], and alcohol [16]. For tobacco
addiction specifically it was found that tDCS could not only reduce craving, but also cigarette
consumption [17–21].
In a double-blind, sham-controlled, crossover study, Fecteau and colleagues [17] found that
five tDCS sessions on consecutive days could decrease cigarette consumption for up to 4 days
in participants who wanted to quit smoking. In another study where smokers were not plan-
ning to quit smoking in the next three months, results showed that cigarette consumption tem-
porarily decreased after one session of tDCS [18]. Recently, it was found that five sessions of
tDCS could decrease cigarette consumption for up to 4 weeks [19]. Here, motivation to quit
modulated the effect of active tDCS on cigarette consumption. The results of these studies sug-
gest that a variety of tDCS protocols could cause a decrease in cigarette consumption and crav-
ing. In addition, it was found that multiple sessions of tDCS may even provide a promising
substitute to bupropion treatment in tobacco addiction [20]. Findings from a recent meta-
analysis indicate that anodal tDCS over the right DLPFC with cathodal tDCS over the DLPFC
had the most positive effects on smoking behaviour [21].
However, the exact parameters of the effectiveness of this specific tDCS protocol remain
unknown. For example, it is unclear how many sessions are needed for tDCS to be effective in
tobacco addiction and for how long the effects last beyond one-month follow-up. Recently, it
was shown that 20 sessions of anodal tDCS over the left DLPFC may reduce cigarette con-
sumption beyond one-month follow-up [20]. The current study will explore whether the pro-
tocol with anodal tDCS over the right DLPFC can also have extended effects on smoking
behaviour with fewer sessions. Ad libitum smokers were included to pilot whether tDCS affects
the natural course of smoking behaviour, without smokers being motivated to quit.
For the current study we choose to measure smoking behaviour by means of Ecological
Momentary Assessment (EMA). Effects of tDCS on addictive behaviour have often been mea-
sured with retrospective self-reports in the lab. Since craving and substance use are both epi-
sodic phenomena that are associated with affect and context [22–24], measuring these
variables in daily life may lead to more reliable answers. Furthermore, retrospective measure-
ments may be influenced by recall biases [25, 26]. EMA therefore establishes more ecologically
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valid results as compared to retrospective self-reports by collecting data in real-time
repeatedly.
In sum, the aim of the current study is to explore the duration of the effect of repetitive
tDCS on cigarette consumption by means of EMA in a sample of ad libitum smokers. Follow-
ing the design of Falcone and colleagues [18], participants were included if they had no plans
to actively try to quit smoking in the next three months. In line with previous studies, we
expected that active tDCS can reduce the number of daily smoked cigarettes and we hypothe-
sized that this decrease can last for up to 3 months after the last session. We also expected




Seventy-three participants signed the informed consent form and completed the first tDCS
session. Inclusion criteria were: 1) Between the age of 18 and 65 years; 2) Currently smoking
10 cigarettes or more a day; 3) The ability to speak, read, and write in Dutch. Exclusion criteria
were: 1) Current substance use disorder of a substance other than nicotine or caffeine; 2) His-
tory of neurological or psychiatric disorders; 3) Any contraindication for electrical brain stim-
ulation procedures (i.e. electronic implants or metal implants); 4) Pregnancy or breast-
feeding; 5) Intentions to actively try to quit smoking in the next three months. Participants
were recruited via advertisement at Erasmus University Rotterdam from October 2016 until
March 2018 and received either course credit or a financial compensation of 20 euro. Two par-
ticipants dropped out during the intervention week, because of personal circumstances (n = 1)
and because of schedule issues (n = 1). Also due to schedule issues, three participants received
tDCS on only two instead of three days. Leaving these participants out of analyses had no effect
on the results, therefore they were included in the final analyses. Nine participants could not
be reached after three months and were therefore lost to follow-up, leaving a total of 62 partici-
pants for follow-up analyses (Fig 1).
The study was approved by the Medical Ethics Committee of the Erasmus Medical Center,
Rotterdam, the Netherlands. All procedures were carried out after participants were fully
informed and had signed a written informed consent form. This report is part of the pre-regis-
tered study with identifier NCT03027687 at ClinicalTrials.gov. The complete study protocol
can be found at http://dx.doi.org/10.17504/protocols.io.bcgdits6.
Experimental design
The current study had a double-blind, randomized, sham-controlled design in which subjects
received a total of six tDCS sessions (active or sham) on three days in one week with at least
one day in between (Fig 2). Participants were first randomly assigned to either sham or active
tDCS. Then, before the tDCS sessions and at three months follow-up, participants completed
the Fagerstro¨m Test of Nicotine Dependence (FTND; [28]). Breath carbon monoxide concen-
trations were also measured using a Micro+ Smokerlyzer (Bedfont Scientific Ltd., Rochester,
UK) to objectively define smoking. In addition, participants completed two behavioural tasks
in the Erasmus Behavioural Lab (EBL) before the first session, one day after the last tDCS ses-
sion and at three months follow-up. With these tasks we measured changes in cognitive con-
trol and feedback processing by means of EEG. The results of the tasks will be discussed
elsewhere, in order to remain focus on the scope of this paper (e.g. changes in smoking behav-
iour after tDCS).
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To measure changes in smoking behaviour, participants were asked to keep track of their
cigarette consumption, craving and affect in an application on their mobile phones (EMA).
Questions in the application were presented at four random times a day for three weeks in
total (random assessments; RA’s), starting the week before the first tDCS session (T1). After
three months, participants were asked to fill out the same four-time daily random assessments
for one more week (T2). In addition, participants were asked to start a session every time they
smoked a cigarette (user-initiated smoking assessment; SA) for three months in total. An ‘end
Fig 1. Flow diagram.
https://doi.org/10.1371/journal.pone.0233414.g001
Fig 2. Experimental procedure.
https://doi.org/10.1371/journal.pone.0233414.g002
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of the day’ assessment (EA) was also implemented for three months, which asked participants
to fill out the total number of smoked cigarettes of that day.
Participants are asked to fill out the following EMA assessments: Random assessments
(RA’s), end of the day assessments (EA’s), user-initiated smoking assessment (SA’s). TDCS
sessions last 13 minutes each with 20 minutes in between.
Transcranial Direct Current Stimulation (tDCS)
Participants in the active tDCS group received tDCS by an electric DC-plus stimulator (Neuro-
Conn, Ilmenau, Germany) via a pair of carbonated silicone electrodes with a thick layer of
high-conductive EEG gel underneath them (35 cm2). During each session, tDCS was applied
two times for 13 minutes with a 20-minute break in between, and a current intensity of 2.0 mA
with a 30 sec ramp at the beginning and end of the session [14]. The anodal electrode was
placed over F4 area (10–20 international system) to stimulate the right DLPFC, the cathodal
electrode was placed over the F3 (left DLPFC). Beneficial effects were found on smoking
behaviour with this ‘right anodal/left cathodal’ positioning [17].
The control group received sham tDCS by the DC-plus stimulator. For sham, the electrodes
were positioned at the same locations as active tDCS, but in this case the stimulator was gradu-
ally turned off after 30 s. Since the itching sensation of tDCS is often only experienced initially
during stimulation, subjects remained blinded of the stimulation condition they received [e.g.
8, 29]. The experimenter was also blinded from the tDCS condition. That is, the codes that can
automatically activate sham or active tDCS, were randomly assigned to participant numbers
by an independent researcher. Then, the experimenter assigned the participant numbers.
Ecological momentary assessment
Procedure. The LifeData platform (www.lifedatacorp.com) was used to develop the
application for this study and to securely collect data. Participants were instructed by email to
download the LifeData application on their smartphone one week before the first tDCS ses-
sion. The start-up session of the application provided general information about how to use
the app. After participants had finished the start-up session, they received random prompts
four times a day between 10 am and 10 pm for 21 consecutive days to complete a RA. After
three months, the application automatically started prompting participants again for four
times a day for seven consecutive days. All RA’s that were not completed within 90 minutes
after the notification disappeared and were marked as missed.
In addition, participants were asked to initiate an assessment whenever they started smok-
ing a cigarette (SA). The application further alerted participants at the end of the day (22 pm)
to fill out the total number of cigarettes they had smoked during the day (end-of-day assess-
ment; EA). EA’s were prompted for 90 consecutive days, starting from the day the application
was downloaded.
Measures. Cigarette consumption. During RA’s, participants were asked how many ciga-
rettes they had smoked since the last assessment and how many minutes had passed since they
had smoked their last cigarette. Participants were also instructed to start a SA whenever they
smoked a cigarette. During EA’s participants filled out the total amount of cigarettes they had
smoked during the day.
Craving. During RA’s, participants were asked to indicate the urge to smoke a cigarette at
that moment on a Likert scale ranging from 0 (no urge) to 100 (very strong urge).
Mood. General mood was measured during RA’s by a prompt stating: “What is your general
mood at the moment?” with response possibilities ranging from very negative (0) to very posi-
tive (5). In addition, participants were asked to evaluate the following specific affects for
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themselves on a 5-point Likert scale: Happiness, enthusiasm, relaxedness, irritability, sadness,
stress, and how bored they felt.
Data analyses
In order to fit the nested data structure of Time within individuals (Level 1), and Group (tDCS
vs. Sham) at Level 2, the primary analysis was conducted using multilevel regression modeling,
also known as hierarchical linear modeling (see [30] for further details), in HLM 7.01. By
using the maximum likelihood estimation method in multilevel modelling of the EMA data,
all data points of individuals with missing data could be analyzed [31]. Missing data is almost
inevitable in EMA studies, since most participants miss at least some prompts due to daily
activities.
For the analyses, first a baseline model was fitted to every outcome variable (cigarette con-
sumption and craving), including random intercepts across participants. With this model, it
was assessed whether multilevel analysis was required. By significant variance at Level 2, the
other models were fitted. It was confirmed that multilevel analyses could be applied in the cur-
rent study, because fitting the baseline models to the data showed there was a significant
amount of variance of the regression coefficients on the subject level (Level 2). The second
model included the Level 1 predictor Time as fixed effect and was then extended by adding
random slopes for Time. The final model included cross-level interactions between Time at
Level 1 and the predictor variable Group (Active or Sham tDCS) at Level 2. The assumptions
of normality and linearity were assessed by inspecting the residuals of each best fitted model.
Unless otherwise reported, the assumptions were met. Further analyses examined smoking
behaviour as a function of craving, and positive and negative affect on the momentary level
(Level 1).
Since age and craving significantly differed for the sham and active tDCS group, multilevel
analyses with cigarette consumption as outcome variable were also carried out with age and
craving as covariates. Both covariates did not influence the results of tDCS on cigarette con-
sumption. Explorative analyses were performed with the following covariates: Gender, overall
FTND scores at baseline, and number of years the participant had been smoking. These vari-
ables had no influence on the effect of tDCS on cigarette consumption and craving. Finally,
Spearman correlation coefficients were calculated for all three carbon monoxide scores on the
one hand and mean number of cigarettes indicated by EA’s in the week before each carbon
monoxide concentration was measured on the other hand.
Results
Descriptive statistics
The final sample consisted of 71 participants (36 females, 35 males) between the age of 19 and
53 years (M = 22.3, SD = 4.7) who smoked an average of 11.3 cigarettes a day (SD = 4.2) and
had a mean FTND score of 3.4 (SD = 1.9). Of these 71 participants, 35 received active tDCS
and 36 received sham treatment. Because of the double-blind method the groups were not
matched at baseline. As a result, the average age of the sham group (M = 23.4) was slightly
higher compared to the active tDCS group (M = 21.1), t(69) = 2.119, p = .038. In addition, the
active tDCS group experienced more craving at baseline (p = .001). For follow-up analyses, 62
participants were included (n = 30 Sham tDCS, n = 32 Active tDCS).
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Ecological momentary assessment: Compliance
RA’s were initially prompted four times a day for 21 days, which means that the total number
of possible prompts for 71 participants was 5964. The total number of completed RA’s during
the first 21 days was 2650. Therefore, the compliance rate for completed random assessments
was 44.4%. Ninety days after the start-up session, RA’s were prompted for one more week.
During this follow-up week the compliance rate was 46.6%.
In addition, EA’s were presented on each day for 90 days. During the first 21 days, partici-
pants completed a total of 810 out of 1491 EA’s (54.3% compliance rate). During the follow-up
week, 62 participants completed 242 out of 434 possible EA’s, making the compliance rate
55.8%.
Additional exploratory analyses showed that 54 participants filled out at least one third of
all EA’s, and 38 participants filled out at least 50% of all EA’s. Further analyses with these two
groups showed no difference in results on the primary outcomes as compared to analyses with
the entire sample. In addition, compliance on EA’s did not correlate with the outcome mea-
sures for both groups.
Primary outcome: Number of smoked cigarettes
The primary outcome measure was mean number of smoked cigarettes a day. Multilevel analy-
sis with mean number of smoked cigarettes as dependent variable and time in days as predic-
tor, showed that the mean number of smoked cigarettes slightly decreased over two weeks’
time from the first tDCS intervention up to one week after the last tDCS session (b = -.07, t
(471) = -2.086, p = .038). This decrease over time was observed for both active tDCS and sham
tDCS (Fig 2) and did not correlate with EMA compliance. Importantly, no differences were
found between the groups in the amount of change over time on number of smoked cigarettes
(p = .745). Also at follow-up, the sham tDCS and active tDCS group did not differ in number
of smoked cigarettes (p = .859).
Correlational analyses: CO scores
Additional analyses showed that number of smoked cigarettes in the week before the first
tDCS session correlated with the breath concentration of carbon monoxide (CO; in parts per
million) on the day of the first tDCS session (r = .416, p< .001). CO scores on the day of the
last tDCS session also correlated with the mean number of cigarettes smoked during the inter-
vention week (r = .303, p = .041). Finally, it was found that mean number of smoked cigarettes
in the week before the follow-up session correlated with CO scores at follow-up (r = .486, p<
.001).
Secondary outcomes: Craving and affect
Participants in the active tDCS group experienced significantly more craving (p< .001) the
week before the first tDCS session (M = 56.1, SD = 20.7) as compared to the sham tDCS group
(M = 48.7, SD = 19.6). Multilevel analysis with craving for cigarettes as dependent variable and
time in days as predictor, showed a main effect of group in the two weeks after the first tDCS
session (b = 11.75, t(69) = 3.87, p = .003), meaning that the baseline difference in craving was
maintained throughout T1. There was no main effect of time (p = .184) and no interaction
effect of time and groups (p = .970) on craving at T1 (Fig 3). No differences between groups
were found for overall mood at T1 (p = .599). For T2 at 3 months follow-up, no main effect of
time and condition, or interaction effect was found for craving and overall mood.
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Analyses at T1 showed that total number of smoked cigarettes was associated with craving
on the same day (b = .035, p< .001). In addition, smoking behaviour was related to positive
affect. Specifically, it was found that happiness was positively related to total number of
smoked cigarettes on the same day (b = .726, p< .001).
tDCS side effects
Side effects were recorded after each tDCS session. Participants were asked to indicate the
amount of itching, burning, and tingling sensations on a 5-point Likert scale, ranging from
none (1) to extreme (5) sensations. In addition, we asked participants about difficulties with
concentrating and whether they experienced acute mood changes during tDCS. Questions
about sleepiness, neckpain and pain in the head were also rated on a 5-point Likert scale.
Results showed that overall, the active tDCS group experienced significantly more itching sen-
sations (F = 11.379, p = .001) as compared to the sham group. No other differences between
the groups were observed regarding the side-effects.
Discussion
The current study was the first to use mobile Ecological Momentary Assessments (EMA) to
investigate non-invasive neurostimulation as a tool to reduce smoking behaviour. The aim of
this exploratory study was to test with EMA whether tDCS over the right DLPFC could modu-
late cigarette consumption and craving in ad libitum tobacco smokers. Results showed that
over the course of the intervention week, the number of smoked cigarettes decreased during
the application of sham or active tDCS. This finding is consistent with observations from a
previous study with multiple tDCS sessions in tobacco smokers [17] and may result from the
participants’ awareness of their smoking behaviour.
Fig 3. Number of smoked cigarettes on each day starting from one week before the 1st tDCS session.
https://doi.org/10.1371/journal.pone.0233414.g003
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Most importantly, however, no differences were found between the sham and active tDCS
group in cigarette consumption and craving. This finding is not in line with a series of previ-
ous studies that have demonstrated that tDCS is effective in reducing cigarette smoking [17–
20] and cigarette craving [11, 12]. A possible explanation for this unexpected finding is that in
the current study craving and cigarette consumption were assessed by means of EMA. With
this experience sampling method, we were able to measure cigarette consumption and craving
in real time. The outcomes are therefore measured in a more ecologically valid manner as
compared to retrospective self-reports. This is of importance, since smoking behaviour is asso-
ciated with mood and context [23, 24]. Individuals may for instance smoke more during the
weekend or on stressful days [31]. This pattern of change over time is clearly illustrated in Figs
3 and 4. Moreover, with the use of momentary assessments retrospective recall biases can be
avoided.
Another explanation for the lack of effect of tDCS on craving levels and cigarette consump-
tion can be found in the study’s sample that consisted of mostly light smokers who, in addition,
had no desire to quit smoking. It can be suggested that motivation of smokers to quit plays an
important role in the efficacy of tDCS. The current study included ad libitum smokers (i.e.,
individuals who have no intention to quit smoking at the moment of the intervention),
whereas a recent study that was published after we started our data collection showed that the
effect of tDCS on smoking behaviour was modulated by motivation to quit [19]. It was also
found that repetitive tDCS decreased cigarette consumption in participants who wanted to
quit smoking [17]. These findings, in combination with the results of the present study, seem
to suggest that tDCS is at least effective if there is a clear motivation to quit smoking. Future
studies should explore the direct relationship between motivation to quit smoking and the effi-
cacy of tDCS on smoking behaviour.
Finally, in contrast with previous studies that applied multiple sessions of tDCS, we applied
6 tDCS sessions on three different days in one week, instead of 5 or more session on at least
five different days [e.g. 17, 20]. A reduction in cigarette consumption could nevertheless be
expected on the days that tDCS was applied. That is, since Falcone and colleagues [18] found
an immediate temporary effect of one tDCS session on smoking in ad libitum smokers. In this
study, however, tDCS was applied online during cue exposure which may have influenced the
effects [18].
Besides the important improvement of using real-time assessment in the natural environ-
ment of smokers, several critical remarks can be made and therefore caution should be taken
when interpreting the findings. First, while participants were randomly allocated to either the
active or sham condition, groups significantly differed on baseline craving levels. That is, par-
ticipants in the active condition showed higher craving levels before the intervention com-
pared to the control group which could have affected the results of this study.
A second limitation that should be mentioned is the relatively low compliance rate, ranging
from 44% to 56%, on EMA assessments. A recent meta-analysis has shown that the average
compliance rate in substance dependent samples is 69.8% [32]. Even though multilevel model-
ling in HLM 7.01 reliably corrects for random missing data, we performed additional analyses
where participants with low compliance rates were excluded to investigate whether compliance
rate might have influenced the outcomes. The results of these analyses indicated no change in
outcome if compliance rates are higher. Reliability of the data is further supported by the find-
ing that carbon monoxide concentrations correlated with number of smoked cigarettes as
indicated in EMA end of the day assessments. Moreover, the EMA data showed that ad libitum
smoking was related to craving and positive affect. Specifically, the number of smoked ciga-
rettes increased with both craving and positive affect on the same day. These findings are in
accordance with the results from an earlier EMA study with a higher compliance rate [22].
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Finally, participants in the active tDCS group indicated they experienced more itching sensa-
tions during neurostimulation than the sham tDCS group. This finding is in line with observa-
tions from previous studies where participants reported tingling and itching sensations after
stimulation [e.g. 17]. However, blinding can still be reliable despite of differences in comfort-
ability between the two conditions [33]. In addition, blinding with sham tDCS is considered
reliable [29].
This was the first exploratory investigation using EMA to study the effects of tDCS on
smoking behaviour. With the use of EMA, further insights were provided on the course of
smoking behaviour over time. In sum, we did not find evidence that tDCS over the DLPFC
decreases cigarette consumption and cigarette craving in light smokers that have no desire to
quit at the moment of intervention. These findings raise intriguing questions regarding the
nature and extent of the effects of tDCS on smoking behaviour. In a previous study it was
found that motivation to quit smoking modulated the efficacy of tDCS on smoking behaviour
[19], and therefore it may be necessary for smokers to actually quit smoking or at least be moti-
vated to quit smoking at the moment of intervention. Future studies should explore this
hypothesis by investigating the effects of repetitive tDCS in a larger sample of heavier smokers
who are motivated to quit.
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Fig 4. Mean craving on each day starting from one week before the 1st tDCS session.
https://doi.org/10.1371/journal.pone.0233414.g004
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